Taken together, these results demonstrate that ADSCs drive ANGPTL4 mRNA and protein expression in CRC cells, and high ANGPTL4 expression levels are associated with a poor prognosis in patients with CRC. This evidence concerns the gene ANGPTL4 and colorectal carcinoma.